San Francisco area: testosterone replacement study, injection vs. patch
Abstract
A 24-week San Francisco study will compare testosterone replacement via injection or patch versus placebo. Participants will be given 200 mg of testosterone enanthate every two weeks, or the patch (Testoderm) to wear on the scrotum. Study-required treatments and tests are free, except for an initial test of testosterone level. Men must be seventeen years old or older. Additional comments highlight a new patch that can be worn on other parts of the body besides the scrotum, and a new testosterone replacement gel which has yet to be approved in the U.S.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents
- On model selections for repeated measurement data in clinical studies
- Regulation of GLUT transporters by flavonoids in androgen-sensitive and -insensitive prostate cancer cells
- Region-specific microRNA signatures in the human epididymis
- Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety
- In Vitro characterization of the endocrine disrupting effects of per- and poly-fluoroalkyl substances (PFASs) on the human androgen receptor
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.